Current and historical gross, operating and net profit margins for Dr Reddy's Laboratories (RDY) over the last 10 years. The current net profit margin for Dr Reddy's Laboratories (RDY) as of March 31, 2018 is 6.9%.
||Medical - Generic Drugs
Doctor Reddy's is an emerging global pharmaceutical company with proven research capabilities. They are vertically integrated with a presence across the pharmaceutical value chain. They produce finished dosage forms, active pharmaceutical ingredients and biotechnology products and market them globally, with focus on India, US, Europe and Russia. They conduct research in the areas of cancer, diabetes, cardiovascular, inflammation and bacterial infection